These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18519749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.
    Rihani A, Van Maerken T, De Wilde B, Zeka F, Laureys G, Norga K, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J.
    Pediatr Blood Cancer; 2014 Oct; 61(10):1867-70. PubMed ID: 24391119
    [Abstract] [Full Text] [Related]

  • 3. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.
    Perfumo C, Parodi S, Mazzocco K, Defferrari R, Inga A, Scarrà GB, Ghiorzo P, Haupt R, Tonini GP, Fronza G.
    Pediatr Blood Cancer; 2009 Oct; 53(4):576-83. PubMed ID: 19526525
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4123-9. PubMed ID: 17634539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.
    Nan H, Qureshi AA, Hunter DJ, Han J.
    Cancer Causes Control; 2009 Mar 15; 20(2):171-9. PubMed ID: 18814047
    [Abstract] [Full Text] [Related]

  • 8. MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma.
    Parodi S, Perfumo C, Garaventa A, Inga A, Mazzocco K, Defferrari R, Tonini GP, Fronza G, Haupt R.
    Pediatr Blood Cancer; 2010 Aug 15; 55(2):267-72. PubMed ID: 20232446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H, Sümbül AT, Bayram S, Bekar A, Akgöllü E.
    Cancer Epidemiol; 2010 Aug 15; 34(4):448-52. PubMed ID: 20447891
    [Abstract] [Full Text] [Related]

  • 15. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
    Khatri RG, Navaratne K, Weil RJ.
    J Neurosurg; 2008 Nov 15; 109(5):842-8. PubMed ID: 18976073
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.
    Zhang X, Pageon L, Post SM.
    Oncogene; 2015 Aug 13; 34(33):4412-20. PubMed ID: 25435368
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.
    Assmann G, Voswinkel J, Mueller M, Bittenbring J, Koenig J, Menzel A, Pfreundschuh M, Roemer K, Melchers I.
    Clin Exp Rheumatol; 2009 Aug 13; 27(4):615-9. PubMed ID: 19772793
    [Abstract] [Full Text] [Related]

  • 20. Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.
    Copson ER, White HE, Blaydes JP, Robinson DO, Johnson PW, Eccles DM.
    BMC Cancer; 2006 Mar 24; 6():80. PubMed ID: 16563154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.